# Methylation Analysis of Circulating Tumor DNA in Gastric Cancer

> **NCT04511559** · — · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 540 (estimated)

## Conditions studied

- Stomach Neoplasms
- Circulating Tumor DNA

## Interventions

- **DIAGNOSTIC_TEST:** Circulating Tumor DNA Methylation Sequencing
- **DIAGNOSTIC_TEST:** tissue DNA Methylation Sequencing

## Key facts

- **NCT ID:** NCT04511559
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-01
- **Primary completion:** 2023-09-30
- **Final completion:** 2025-05-01
- **Target enrollment:** 540 (ESTIMATED)
- **Last updated:** 2020-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04511559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04511559, "Methylation Analysis of Circulating Tumor DNA in Gastric Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04511559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*